Immunohistochemical (IHC) staining demonstrated a progressive increase in ASIC1 expression across advancing tumor stages, with significantly higher ASIC1 levels observed in Stage III compared to earlier stages (Figure 1C–E). Here, ASIC1 is linked to neoplasm.